Regeneron Pharmaceuticals/ US75886F1075 /
31/05/2024 21:59:45 | Diferencia +9.74 | Volumen | Bid- | Ask- | Capitalización de mecado | Dividendo A. | P/E Ratio |
---|---|---|---|---|---|---|---|
980.13USD | +1.00% | 26,891 Volumen de negocios: 26.21 millones |
-Volumen de oferta: - | -Tamaño/ Volumen/ Formato de Ask: - | 108 mil millonesUSD | - | 26.46 |
GlobeNewswire
10:00
BioCryst Presents New Real-world Evidence Showing Reductions in Attack Rates in HAE Patients with No...
GlobeNewswire
3:00
BIOGEN ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Fil...
Newsfile Corp
2:24
OPPO Scores Unforgettable Experiences with Global Brand Ambassador Kaka' at the UEFA Champions Leagu...
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página